Sinusoidal obstruction syndrome post-treatment with trastuzumab emtansine (T-DM1) in advanced breast cancer

Trastuzumab emtansine (T-DM1) is an antibody–drug conjugate approved for use in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer. Here, we present the cases of two patients with metastatic breast cancer who received T-DM1 monotherapy and developed noncirrho...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int Cancer Conf J
Glavni autori: Fujii, Yasutoshi, Doi, Mihoko, Tsukiyama, Naofumi, Hattori, Yui, Ohya, Kazuki, Shiroma, Noriyuki, Morio, Kei, Morioka, Takehiko, Aikata, Hiroshi, Shinozaki, Katsunori, Chayama, Kazuaki
Format: Artigo
Jezik:Inglês
Izdano: Springer Singapore 2019
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6942611/
https://ncbi.nlm.nih.gov/pubmed/31950012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-019-00392-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items